FERAYDOON KOHAN, MD
Cardiovascular Disease Physician in JERSEY CITY, New Jersey. CMS National Plan and Provider Enumeration System profile including specialty classification, practice address, and Medicare prescribing data when reported.
What the federal data shows
FERAYDOON KOHAN, MD reported a CMS MIPS final score of 92.4724/100 — above the 83.1 national average — and filed 11,696 Medicare Part D claims in 2023.
- 92.4724/100
- MIPS score · +9 vs avg
- 12K
- Part D claims, 2023
- Likely
- board-certified (heuristic)
Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) — no proprietary rating or editorial opinion is applied.
FERAYDOON KOHAN, MD's MIPS score vs every scored U.S. clinician
CMS Merit-based Incentive Payment System (MIPS) final score, 2023 — the federal quality measure
92 Top 32% higher than 68% of 477,587 scored providers
Each bar is a band; taller bars hold more scored providers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source CMS Merit-based Incentive Payment System (MIPS) · 2023
FERAYDOON KOHAN, MD practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + MIPS quality reporting — signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).
What does the federal data show about FERAYDOON KOHAN, MD?
High performer (top quartile)Primary specialty
Medicare Part D claims
MIPS final score
Specialty distribution in New Jersey
How Cardiovascular Disease Physician compares to other specialties among New Jersey providers
Cardiovascular Disease Physician share within New Jersey
Cardiovascular Disease Physician is one of the more visible NUCC categories in New Jersey
Each bar reflects the share of in-state providers whose primary NUCC taxonomy matches the specialty. Long tail of ~690 NUCC codes folded into "Other" to keep the comparison legible.
Medicare quality performance — MIPS
FERAYDOON KOHAN, MD's 2023 MIPS final score plotted against the Cardiovascular Disease Physician national average
- MIPS Final Score
- 92.4724/100
- vs 83.1 national avg · 2023 performance year
MIPS final score (Cardiovascular Disease Physician) — 92.4724/100 vs national avg 83.1
Quality benchmarks
- National MIPS avg 2023 reporting year
- Quality dim CMS Quality category
- Cost dim CMS Cost category
- Specialty volume Cardiovascular Disease Physician US NPIs
92.4724/100 MIPS final score — 9.4 pts above the 83.1 national average
Quality, Cost, Promoting Interoperability, and Improvement Activities composite score for the 2023 performance year. Specialty: Cardiovascular Disease Physician. Quality dim: 92.9807. Cost dim: 67.6005.
The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.
Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).
FERAYDOON KOHAN, MD appears in the CMS NPPES registry as a Cardiovascular Disease Physician provider holding MD credentials at 550 NEWARK AVE, JERSEY CITY, NJ, 07306, with a listed phone of (201) 222-9900. NPI 1831134311 was issued on 06/18/2006. Because NPPES data is self-reported by the provider and refreshed monthly, the address, phone, and specialty reflect what KOHAN most recently submitted to CMS rather than a vetted directory listing, which is why patients should always confirm the practice is still at this location before scheduling.
Medicare Part D records for calendar year 2023 show 11,696 prescription claims written by this provider, covering 1,017 Medicare beneficiaries and totaling roughly $1.9 million in drug spend. These figures capture only Medicare Part D — commercial insurance, Medicaid, and cash-pay prescriptions are not included, and any drug-beneficiary cell under 11 is suppressed by CMS for patient privacy. On the CMS Merit-based Incentive Payment System, this provider earned a Final Score of 92.4724/100 for the 2023 performance year (Quality 92.9807, Cost 67.6005), compared with the national average of 83.1.
Cardiovascular Disease Physician is a mid-sized specialty nationwide, with 24,795 enrolled providers across 54 states and an average of 3,033 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline. Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist — always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.
Practice Address
Provider Details
| NPI | 1831134311 |
|---|---|
| Specialty | Cardiovascular Disease Physician |
| Credentials | MD |
| Gender | Male |
| NPI Issued | 06/18/2006 |
Verify this provider's license
PlainDoctor pulls this profile from the CMS NPPES public registry. Confirm FERAYDOON KOHAN, MD's current license status, disciplinary history, and board certifications with the New Jersey State Board of Medical Examiners in New Jersey before relying on this page for a clinical or care decision.
How we sourced this profile
CMS Quality Score (MIPS)
Merit-based Incentive Payment System (MIPS) scores from CMS, 2023 performance year.
Reporting: Individual
Industry payments received (2024) — CMS Open Payments transparency data
The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for FERAYDOON KOHAN, MD. Source: openpaymentsdata.cms.gov.
Total received
$1.4K
Largest payer
Amgen Inc.
Most common payment type
Food and Beverage
Industry payments are not necessarily indicators of bias — they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.
Medicare Part D Prescribing Data
CMS Medicare Part D prescriber-level data for calendar year 2023.
Prescribing Breakdown
- 30-Day Fills
- 20,300
- Total Day Supply
- 605,401
- Generic Drug Cost
- $301K
- Antibiotic Claims
- 33
Patient Demographics
- Average Patient Age
- 74.0 years
- Avg HCC Risk Score
- 1.72
- Gender Split
- 58% female / 42% male
- Age Distribution
- <65: 87, 65-74: 459, 75-84: 362, 85+: 109
Top Prescribed Drugs (Medicare Part D)
Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.
What FERAYDOON KOHAN, MD prescribes most
Top Medicare Part D drugs by claim count, 2023
- Amlodipine Besylate
Amlodipine Besylate
918 claims
- Atorvastatin Calcium
Atorvastatin Calcium
879 claims
- Eliquis
Eliquis
489 claims
- Entresto
Entresto
447 claims
- Losartan Potassium
Losartan Potassium
445 claims
- Metoprolol Succinate
Metoprolol Succinate
441 claims
- Clopidogrel
Clopidogrel
430 claims
- Carvedilol
Carvedilol
408 claims
| Drug | Claims |
|---|---|
| Amlodipine Besylate | 918 |
| Atorvastatin Calcium | 879 |
| Eliquis Apixaban | 489 |
| Entresto Sacubitril/Valsartan | 447 |
| Losartan Potassium | 445 |
| Metoprolol Succinate | 441 |
| Clopidogrel Clopidogrel Bisulfate | 430 |
| Carvedilol | 408 |
| Valsartan-Hydrochlorothiazide Valsartan/Hydrochlorothiazide | 371 |
| Rosuvastatin Calcium | 362 |
* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.
Cardiovascular Disease Physician Overview
How FERAYDOON KOHAN, MD fits within the Cardiovascular Disease Physician landscape nationally.
FERAYDOON KOHAN, MD's 11,696 claims are above the specialty average of 3,033.
Nearby Cardiovascular Disease Physician Providers in New Jersey
Other clinicians with the same primary specialty enrolled in New Jersey, drawn from the same CMS NPPES roster as KOHAN.
Compare Cardiovascular Disease Physician nationally: see state-by-state distribution →
Healthcare Guides
Learn more about finding, verifying, and understanding healthcare providers.
Explore New Jersey
Frequently Asked Questions
What is FERAYDOON KOHAN, MD's specialty? ▼
How much does FERAYDOON KOHAN, MD prescribe under Medicare Part D? ▼
What is FERAYDOON KOHAN, MD's Medicare quality score? ▼
Where is FERAYDOON KOHAN, MD located? ▼
What is FERAYDOON KOHAN, MD's NPI number? ▼
How many Cardiovascular Disease Physician providers are there in the US? ▼
What drugs does FERAYDOON KOHAN, MD prescribe most often? ▼
Does FERAYDOON KOHAN, MD accept Medicare? ▼
How can I verify FERAYDOON KOHAN, MD's credentials? ▼
Data Sources
- Provider Directory
- CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
- Specialty Classification
- NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
- Prescribing Data
- CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
- Quality Performance
- CMS Merit-based Incentive Payment System (MIPS) — 2023 performance year.
- Limitations
- Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.
See our complete data methodology for details on how we collect and process government data.
Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).
Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology